In a meeting with govt officials, drug-makers flagged concerns that their clients may start buying products from other countries if restrictions on Indian products continued.
Despite being the leading supplier of medicines across the globe, Indian pharma industry heavily depends on China for ingredients used to make even basic drugs.
In meeting chaired by Niti Aayog CEO Amitabh Kant, govt asks top Indian pharma firms to amp up production of these 38 raw materials, technically called APIs.
ThePrint had reported that PM Modi told pharma companies to stop bribing doctors. IPA secy general had said he didn’t have any information about such a meeting.
In her May 2019 book Bottle of Lies, Katherine Eban accused Indian pharma firms of major lapses such as ‘toxic impurities’ and fudging data on quality control.
India has one of the lowest drug prices in the world, yet many Indians are deprived of life-saving drugs. Price controls haven't been enough to bridge this gap.
Mini deal will likely see no cut in 10% baseline tariff on Indian exports announced by Trump on 2 April, it is learnt, but additional 26% tariffs are set to be reduced.
PTC Industries is investing Rs 1,000 cr in 4 manufacturing plants in UP, has already started supplying titanium parts to BAE Systems for its M-777 howitzers that India also uses.
Public, loud, upfront, filled with impropriety and high praise sometimes laced with insults. This is what we call Trumplomacy. But the larger objective is the same: American supremacy.
Govt should be utlising production capacity of private sector — units which are making garments/under garments should be making masks. Similarly, all white-goods manufacturers should be making ventilators.
Govt should be utlising production capacity of private sector — units which are making garments/under garments should be making masks. Similarly, all white-goods manufacturers should be making ventilators.